Skip to main content
Search search
Mobile Search:

Nutritional Neuropharmacology Lab

Investigating how hormones influence brain reward circuits

Under the direction of Joshua Gross, The Nutritional Neuropharmacology Lab studies how G protein-coupled receptor (GPCR) signaling regulates food reward in the context of obesity, eating disorders, and metabolic disease. Basic science techniques, including molecular pharmacology in cell-based models to behavioral/physiological analyses using transgenic mice, are employed to study how GPCR-dependent gut hormones (ghrelin, GLP-1), neurotransmitters (dopamine, serotonin), and dietary nutrients (fatty acids) influence brain reward circuits. By understanding the intracellular signaling of "druggable" GPCRs, this work hopes to elucidate a molecular roadmap to enable the design and discovery of new medications or dietary interventions that maximize therapeutic efficacy and minimize side effects.

Josh Gross in a lab coat
Study Spotlight
Can a rare metabolic receptor mutation reshape how we treat metabolic disease?

A new study from the Nutritional Neuropharmacology Lab uses a naturally occurring mutation in the ghrelin receptor to identify novel cellular signaling mechanisms. These findings may have implications for future medication development and precision medicine that could improve human health outcomes.